ES2160191T3 - Deteccion de listerias, mediante bacteriofagos recombinantes. - Google Patents

Deteccion de listerias, mediante bacteriofagos recombinantes.

Info

Publication number
ES2160191T3
ES2160191T3 ES96107225T ES96107225T ES2160191T3 ES 2160191 T3 ES2160191 T3 ES 2160191T3 ES 96107225 T ES96107225 T ES 96107225T ES 96107225 T ES96107225 T ES 96107225T ES 2160191 T3 ES2160191 T3 ES 2160191T3
Authority
ES
Spain
Prior art keywords
proteins
genero
determination
bacteria
dna vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96107225T
Other languages
English (en)
Inventor
Martin J Dr Lossner
Siegfried Prof Dr Scherer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xenogen Corp
Original Assignee
Xenogen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xenogen Corp filed Critical Xenogen Corp
Application granted granted Critical
Publication of ES2160191T3 publication Critical patent/ES2160191T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/77Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00Bacteriophages
    • C12N2795/00011Details
    • C12N2795/10011Details dsDNA Bacteriophages
    • C12N2795/10111Myoviridae
    • C12N2795/10141Use of virus, viral particle or viral elements as a vector
    • C12N2795/10143Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

LA INVENCION TRATA DE UN PROCEDIMIENTO DE DETERMINACION DE BACTERIAS DEL GENERO LISTERIA QUE COMPRENDE LOS SIGUIENTES PASOS: (A) PREPARACION DE UN VECTOR DE ADN OBTENIDO MEDIANTE LAS TECNICAS DE RECOMBINACION, CONTENIENDO UN SISTEMA GENETICO QUE COMPRENDE ADN, QUE CODIFICA LA EXPRESION DE UNA O VARIAS PROTEINAS, NO SIENDO LAS PROTEINAS NINGUN PRODUCTO GENICO DE BACTERIAS DEL GENERO LISTERIA, Y SE PUEDE DETERMINAR LA PRESENCIA DE LAS PROTEINAS POR UNA REACCION DE DETERMINACION, INFECTANDO EL VECTOR DE ADN LAS BACTERIAS DEL GENERO LISTERIA, Y PASANDO POR TANTO EL SISTEMA GENETICO A LAS BACTERIAS; (B) MEZCLA DE LA MUESTRA CON EL CITADO VECTOR DE ADN EN UNAS CONDICIONES QUE PERMITAN LA INFECCION DE BACTERIAS DEL GENERO LISTERIA POR EL VECTOR DE ADN; (C) EXPRESION DE LAS PROTEINAS A DETERMINAR EN LAS BACTERIAS DEL GENERO LISTERIA; (D) DETERMINACION DE LAS PROTEINAS A DETERMINAR, DETERMINANDO LA PRESENCIA DE BACTERIAS DEL GENERO LISTERIA; ASI COMO LOS VECTORES DE ADN APROPIADOS PARA ESTE PROCEDIMIENTO DE DETERMINACION Y COMBINACION DE REACTIVOS.
ES96107225T 1995-05-18 1996-05-08 Deteccion de listerias, mediante bacteriofagos recombinantes. Expired - Lifetime ES2160191T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19517940A DE19517940A1 (de) 1995-05-18 1995-05-18 Nachweis von Listerien mittels rekombinanter Bakteriophagen

Publications (1)

Publication Number Publication Date
ES2160191T3 true ES2160191T3 (es) 2001-11-01

Family

ID=7762052

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96107225T Expired - Lifetime ES2160191T3 (es) 1995-05-18 1996-05-08 Deteccion de listerias, mediante bacteriofagos recombinantes.

Country Status (5)

Country Link
US (1) US5824468A (es)
EP (1) EP0743366B1 (es)
DE (2) DE19517940A1 (es)
DK (1) DK0743366T3 (es)
ES (1) ES2160191T3 (es)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7255851B2 (en) 1994-07-01 2007-08-14 The Board Of Trustees Of The Leland Stanford Junior University Non-invasive localization of a light-emitting conjugate in a mammal
US6649143B1 (en) 1994-07-01 2003-11-18 The Board Of Trustees Of The Leland Stanford Junior University Non-invasive localization of a light-emitting conjugate in a mammal
DE60014987T2 (de) * 1999-02-22 2005-11-10 Matsushita Electric Industrial Co., Ltd., Kadoma Verfahren zum Nachweis von Bakterien
FI107167B (fi) 1999-06-07 2001-06-15 Marko Virta Menetelmä mikro-organismin kasvun ja kuolemisen määrittämiseksi
PT1198713E (pt) 1999-07-30 2006-06-30 Profos Ag Deteccao e identificacao de estirpes bacterianas
US20030096315A1 (en) 2000-05-03 2003-05-22 Sanders Mitchell C. Device for detecting bacterial contamination and method of use
US20020192676A1 (en) * 2001-06-18 2002-12-19 Madonna Angelo J. Method for determining if a type of bacteria is present in a mixture
WO2003035889A2 (en) * 2001-07-13 2003-05-01 Investigen, Inc. Compositions and methods for bacteria detection
US7232564B2 (en) * 2001-07-18 2007-06-19 Instytut Immunologii I Terapii Doswiadczal-Nej Pan Methods of polyvalent bacteriophage preparation for the treatment of bacterial infections
US20050118567A1 (en) * 2002-01-23 2005-06-02 Merril Carl R. Method for determining sensitivity to a bacteriophage
AU2003212897B2 (en) * 2002-01-31 2007-08-02 Expressive Constructs, Inc. Method for detecting microorganisms
US8216780B2 (en) * 2002-04-12 2012-07-10 Microphage (Tm) Incorporated Method for enhanced sensitivity in bacteriophage-based diagnostic assays
US20050003346A1 (en) * 2002-04-12 2005-01-06 Colorado School Of Mines Apparatus and method for detecting microscopic living organisms using bacteriophage
EP1540018B1 (en) * 2002-04-12 2010-05-26 Colorado School Of Mines Method for detecting low concentrations of a target bacterium that uses phages to infect target bacterial cells
PL215172B1 (pl) * 2003-01-31 2013-10-31 Ethicon Inc Sposób wykrywania Escherichia coli, biosensor do wykrywania Escherichia coli i zestaw do wykrywania Escherichia coli
CA2557612C (en) * 2003-11-03 2014-06-17 Ethicon, Inc. Methods, peptides and biosensors useful for detecting a broad spectrum of bacteria
US20050250096A1 (en) * 2004-02-13 2005-11-10 Microphage, Incorporated Microorganism detection using bacteriophage amplification
US20090286225A1 (en) * 2004-02-13 2009-11-19 Microphagetm Incorporated Method and apparatus for bacteriophage-based diagnostic assays
US20090155768A1 (en) * 2004-04-07 2009-06-18 Dean Scholl Reporter plasmid phage packaging system for detection of bacteria
US20110097702A1 (en) * 2005-03-31 2011-04-28 Voorhees Kent J Methods and compositions for in situ detection of microorganisms on a surface
WO2006105414A2 (en) * 2005-03-31 2006-10-05 Colorado School Of Mines Apparatus and method for detecting microscopic organisms using microphage
US20070178450A1 (en) * 2006-01-27 2007-08-02 Microphage (Tm) Incorporation Method and apparatus for determining level of microorganisms using bacteriophage
WO2008063838A2 (en) * 2006-10-31 2008-05-29 Microphage Incorporated Method and apparatus for enhanced bacteriophage-based diagnostic assays by selective inhibition of potential cross-reactive organisms
EP2140018B1 (en) * 2007-04-04 2012-08-01 Guild Associates, Inc. Biological detection system and method
EP2158490A2 (en) 2007-06-15 2010-03-03 Microphage, Incorporated Method of detection of microorganisms with enhanced bacteriophage amplification
US8697434B2 (en) * 2008-01-11 2014-04-15 Colorado School Of Mines Detection of phage amplification by SERS nanoparticles
US9441204B2 (en) * 2008-04-03 2016-09-13 Colorado School Of Mines Compositions and methods for detecting Yersinia pestis bacteria
PL215522B1 (pl) 2008-09-29 2013-12-31 Inst Immunologii I Terapii Doswiadczalnej Pan Nowe szczepy bakteriofagów do leczenia zakazen bakteryjnych, zwlaszcza szczepami bakterii lekoopornych rodzaju Enterococcus
PL212258B1 (pl) 2010-06-20 2012-09-28 Inst Immunologii I Terapii Doswiadczalnej Pan Nowe szczepy bakteriofagów do leczenia zakazen bakteryjnych, zwlaszcza szczepami bakterii lekoopornych rodzaju Stenotrophomonas
WO2012158041A1 (en) 2011-05-18 2012-11-22 Rna Holding B.V. Diagnostic methods and kits for determining the presence of a microorganism in a sample
PL217019B1 (pl) 2011-08-25 2014-06-30 Proteon Pharmaceuticals Spółka Akcyjna Sposób otrzymywania szczepu bakteriofaga, specyficzne szczepy bakteriofagowe oraz ich zastosowanie
US10519483B2 (en) 2012-02-21 2019-12-31 Laboratory Corporation Of America Holdings Methods and systems for rapid detection of microorganisms using infectious agents
WO2013126584A1 (en) * 2012-02-21 2013-08-29 Laboratory Corporation Of America Holdings Methods and systems for detection of microorganisms
US10913934B2 (en) 2013-02-21 2021-02-09 Laboratory Corporation Of America Holdings Methods and systems for rapid detection of microorganisms using infectious agents
WO2014160418A2 (en) 2013-03-13 2014-10-02 GeneWeave Biosciences, Inc. Non-replicative transduction particles and transduction particle-based reporter systems
US9481903B2 (en) 2013-03-13 2016-11-01 Roche Molecular Systems, Inc. Systems and methods for detection of cells using engineered transduction particles
EP2978857A2 (en) * 2013-03-27 2016-02-03 Sample Technologies, Inc. Recombinant phage and bacterial detection methods
AU2014281406A1 (en) 2013-06-19 2016-01-21 Sample6 Technologies, Inc. Phage-based bacterial detection assay
US9540675B2 (en) 2013-10-29 2017-01-10 GeneWeave Biosciences, Inc. Reagent cartridge and methods for detection of cells
WO2015172082A1 (en) 2014-05-09 2015-11-12 Sample6 Technologies, Inc. Codon-optimized recombinant phage and methods of using same
US10351893B2 (en) 2015-10-05 2019-07-16 GeneWeave Biosciences, Inc. Reagent cartridge for detection of cells
CN108884498A (zh) * 2016-01-18 2018-11-23 美国控股实验室公司 使用感染原快速检测微生物的方法和系统
CN111601897A (zh) 2016-12-30 2020-08-28 奎多公司 用于确定细菌对抗生素或益菌剂的易感性的噬菌体介导的免疫分析和方法
CA3076516A1 (en) * 2017-10-02 2019-04-11 Quidel Corporation Phage-based detection method for antimicrobial susceptibility testing and identification of bacterial species
BR112020011688A2 (pt) * 2018-01-12 2020-11-17 Laboratory Corporation Of America Holdings métodos e sistemas para a rápida detecção de salmonella usando agentes infecciosos
CN110579608B (zh) * 2018-06-11 2022-07-08 苏州若泰医药科技有限公司 一种筛选高表达外源蛋白的非整合减毒李斯特菌菌株的方法
MX2021015900A (es) 2019-06-21 2022-02-03 Laboratory Corp America Holdings Metodos para producir bacteriofagos mutantes para la deteccion de listeria.
MX2022002430A (es) 2019-08-26 2022-03-22 Laboratory Corp America Holdings Dispositivos y metodos para detectar microorganismos usando bacteriofago indicador deficiente en reproduccion combinante.
CA3150337A1 (en) 2019-09-11 2021-03-18 Stephen E. Erickson METHODS AND SYSTEMS FOR THE RAPID DETECTION OF MICROORGANISMS USING RECOMBINANT INFECTIOUS AGENTS TO EXPRESS AN INDICATOR SUBUNIT

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68927803T2 (de) * 1988-10-04 1997-07-10 Dna Plant Techn Corp Bakterieller nachweis durch phagentransduktion von nachweisbaren phenotypen
GB9017443D0 (en) * 1990-08-09 1990-09-26 Amersham Int Plc Reporter bacteria for rapid microbial detection
EP0625191A1 (en) * 1992-02-07 1994-11-23 Albert Einstein College Of Medicine Of Yeshiva University Mycobacterial species-specific reporter mycobacteriophages

Also Published As

Publication number Publication date
EP0743366B1 (de) 2001-07-11
DK0743366T3 (da) 2001-10-01
DE19517940A1 (de) 1996-11-21
US5824468A (en) 1998-10-20
EP0743366A1 (de) 1996-11-20
DE59607254D1 (de) 2001-08-16

Similar Documents

Publication Publication Date Title
ES2160191T3 (es) Deteccion de listerias, mediante bacteriofagos recombinantes.
Braun et al. Guanylate-binding proteins 2 and 5 exert broad antiviral activity by inhibiting furin-mediated processing of viral envelope proteins
Pekrun et al. Using a barcoded AAV capsid library to select for clinically relevant gene therapy vectors
Strange et al. Effect of chilling on Aerobacter aerogenes in aqueous suspension
Carrasco et al. Interaction of classical swine fever virus with dendritic cells
Trono et al. Translation in mammalian cells of a gene linked to the poliovirus 5′ noncoding region
Guthrie et al. Infection of protoplasts of Escherichia coli by subviral particles of bacteriophage φX174
Bretscher et al. Polyribonucleotide-directed protein synthesis using an E. coli cell-free system
Bozidis et al. Trafficking of UL37 proteins into mitochondrion-associated membranes during permissive human cytomegalovirus infection
Litvak et al. Elongation factor-viral genome interaction dependent on the aminoacylation of TYMV and TMV RNAs
Hedén Effects of hydrostatic pressure on microbial systems
Stadler et al. Isolation of synaptosomal plasma membranes from cholinergic nerve terminals and a comparison of their proteins with those of synaptic vesicles
CY1112430T1 (el) Λεντινοϊικο τριπλο dνα και οχηματα και ανασυνδυασμενα κυτταρα που περιεχουν λεντινοϊικο τριπλο dνα
Li et al. A single point mutation creating a furin cleavage site in the spike protein renders porcine epidemic diarrhea coronavirus trypsin independent for cell entry and fusion
EP1757689A3 (en) Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
Vanella et al. Enzyme‐mediated hydrogel encapsulation of single cells for high‐throughput screening and directed evolution of oxidoreductases
DE69634300D1 (de) Gentherapie mit hilfe von schaf-adenoviralen vektoren
ES2059361T3 (es) Complejo de proteinas recombinantes que tiene actividad de factor viii:c su produccion y uso.
BR9610511B1 (pt) construções de dna, úteis em terapia genética, compreendendo ao menos uma sequência nucléica de interesse e composição farmacêutica.
Lello et al. nsP4 is a major determinant of alphavirus replicase activity and template selectivity
Masahiro et al. Changes in morphology, buoyant density and protein composition in differentiation from the reproductive short form to the infectious long form of Holospora obtusa, a macronucleus-specific symbiont of the ciliate Paramecium caudatum
ES2144466T3 (es) Metodo de tratamiento de muestras de esputo que contienen mycobacterias.
EA200400021A1 (ru) Способ стабилизации реагента для амплификации или детекции нуклеиновой кислоты и способ хранения
ES2134852T3 (es) Una linea celular tratada por ingenieria genetica para detectar el virus herpes simple infeccioso y metodo para ello.
Bengali et al. Drosophila S2 cells are non-permissive for vaccinia virus DNA replication following entry via low pH-dependent endocytosis and early transcription

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 743366

Country of ref document: ES